A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication
- 1 December 2003
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 84 (12) , 3215-3225
- https://doi.org/10.1099/vir.0.19300-0
Abstract
In an effort to define novel cellular factors regulating human immunodeficiency virus type 1 (HIV-1) replication, a differential display analysis has been performed on endogenously infected cells stimulated with the HIV-suppressive immunomodulator Murabutide. In this study, the cloning and identification of a Murabutide-downregulated gene, named RH116, bearing classical motifs that are characteristic of the DExH family of RNA helicases, are reported. The 116 kDa encoded protein shares 99·9 % similarity with MDA-5, an inducible RNA helicase described recently. Ectopic expression of RH116 in HeLa-CD4 cells inhibited cell growth and cell proliferation but had no measurable effect on programmed cell death. RH116 presented steady state cytoplasmic localization and could translocate to the nucleus following HIV-1 infection. Moreover, the endogenous expression of RH116, at both the transcript and protein levels, was found to be considerably upregulated after infection. Overexpression of RH116 in HIV-1-infected HeLa-CD4 cells also resulted in a dramatic increase in the level of secreted viral p24 protein. This enhancement in virus replication did not stem from upregulated proviral DNA levels but correlated with increased unspliced and singly spliced viral mRNA transcripts. These findings implicate RH116 in the regulation of HIV-1 replication and point to an apoptosis-independent role for this novel helicase in inducing cell growth arrest.Keywords
This publication has 28 references indexed in Scilit:
- Transient Induction of Cyclin T1 during Human Macrophage Differentiation Regulates Human Immunodeficiency Virus Type 1 Tat Transactivation FunctionJournal of Virology, 2002
- Selective Regulation of Human Immunodeficiency Virus-Infected CD4+Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID MiceJournal of Virology, 2001
- Cell-cycle regulation in immunity, tolerance and autoimmunityImmunology Today, 2000
- High Levels of Drug‐Resistant Human Immunodeficiency Virus Variants in Patients Exhibiting Increasing CD4+T Cell Counts Despite Virologic Failure of Protease Inhibitor–Containing Antiretroviral Combination TherapyThe Journal of Infectious Diseases, 2000
- Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic ResponseThe Journal of Infectious Diseases, 2000
- Interleukin‐16 (IL‐16) Inhibits Human Immunodeficiency Virus Replication in Cells from Infected Subjects, and Serum IL‐16 Levels Drop with Disease ProgressionThe Journal of Infectious Diseases, 1999
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutideInternational Journal of Immunopharmacology, 1995
- Splicing Variability in HIV Type 1 Revealed by Quantitative RNA Polymerase Chain ReactionAIDS Research and Human Retroviruses, 1994